H.C. Wainwright Assumes Humacyte (HUMA) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall St turns lower as crude spikes, chip stocks weigh
- Oil jumps 5%, then pares gains after Trump says no attack on Iran this month
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
Tweet
Share
E-mailGet Alerts HUMA Hot Sheet
Price: $0.44 -6.38%
Rating Summary:
6 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 18 | New: 34
Rating Summary:
6 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 18 | New: 34
Join SI Premium – FREE
H.C. Wainwright analyst Swayampakula Ramakanth assumes coverage on Humacyte (NASDAQ: HUMA) with a Buy rating and a price target of $4.00.
For an analyst ratings summary and ratings history on Humacyte click here. For more ratings news on Humacyte click here.
Shares of Humacyte closed at $1.73 yesterday.
You May Also Be Interested In
- Barclays Starts Humacyte (HUMA) at Equalweight
- Nomura/Instinet Resumes AMEC (688012:CH) at Buy
- Guggenheim Starts Centrus Energy Corp. (LEU) at Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
